Rome, Italy

Vergani Domenico

This inventor holds 1 USPTO granted patent. Top assignees: Instituto Nazionale Per Lo Studio E La Cura Dei Tumori, Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vergani Domenico. Retrieved from https://idiyas.com/inventor/vergani-domenico

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vergani Domenico: Innovator in Pharmaceutical Chemistry

Introduction

Vergani Domenico is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Domenico holds a patent for "Camptothecins with a modified lactone ring." This patent describes compounds of formula (I) or (II), where the groups are defined in the detailed description. The patent includes racemic mixtures, individual enantiomers, individual diastereoisomers, their mixtures, and pharmaceutically acceptable salts. These compounds are recognized as topoisomerase I inhibitors, which are crucial in cancer treatment.

Career Highlights

Throughout his career, Vergani Domenico has worked with prominent organizations such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and the Istituto Nazionale per lo Studio e la Cura dei Tumori. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Domenico has collaborated with esteemed colleagues, including Maria Ornella Tinti and Alpegiani Marco. Their joint efforts have contributed to the success of various projects in the pharmaceutical sector.

Conclusion

In summary, Vergani Domenico is a distinguished inventor whose work in pharmaceutical chemistry has led to important advancements in cancer treatment. His innovative contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…